Characterisation of the complement-regulatory proteins decay-accelerating factor (DAF, CD55) and membrane cofactor protein (MCP, CD46) on a human colonic adenocarcinoma cell line

Cancer Immunology Immunotherapy

Volumn 42, Issue 3, 1996, Pages 185-192

  Bjørge, Line ^a   Jensen, Tone Skeie ^a   Matre, Roald ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

cancer biology; CD46 (MCP); CD55 (DAF); complement

Indexed keywords

CD45 ANTIGEN; CD59 ANTIGEN; COMPLEMENT; DECAY ACCELERATING FACTOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; MEMBRANE COFACTOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ADENOCARCINOMA; ANTIGENS, CD; ANTIGENS, CD46; ANTIGENS, CD55; CELL DIVISION; COLONIC NEOPLASMS; HUMANS; MEMBRANE GLYCOPROTEINS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0029923882     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050269     Document Type: Article

References (38)

1. Ballard L, Seya T, Teckman J, Lublin DM, Atkinson JP (1987) A polymorphism of the complement regulatory protein MCP (membrane cofactor protein or gp45-70). J Immunol 138:3850
2. Bjørge L, Vedeler CA, Ulvestad E, Matre R (1994) Expression and function of CD59 on colonie adenocarcinoma cells. Eur J Immunol 24:1597
3. Bora NS, Gobelman CL, Atkinson JP, Pepose JS, Kaplan HJ (1993) Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 34:3579
4. Brown DA, Rose JK (1992) Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68:533
5. Cain TJ, Liu Y, Takizawa T, Robinson JM (1995) Solubilization of glycosyl-phosphatidylinositol-anchored proteins in quiescent and stimulated neutrophils. Biochim Biophys Acta 1235:69
6. Cheung N-KV, Walter EI, Smith-Mensah WH, Ratnoff WD, Tykocinski ML, Medof MH (1988) Decay-accelerating factor protects human tumour cells from complement-mediated cytotoxicity in vitro. J Clin Invest 81:122
7. Favaloro EJ (1993) Differential expression of surface antigens on activated endothelium. Immunol Cell Biol 71:571
8. Guidi L, Baroni R, Bartoloni C, Pellegrino M, Tricerri A, Marciano M, Barone C, Gambassi G (1988) Immune complexes in solid tumours precipitable by 3.5% polyethylene glycol: analysis of some nonspecific components. Diagn Clin Immunol 5:284
9. Hakulinen J, Meri S (1994) Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Lab Invest 71:820
10. Johnstone RW, Loveland BE, McKenzie IFC (1993) Identification and quantitation of complement regulator CD46 on normal human tissues. Immunology 79:341
11. Junnikkala S, Hakulinen J, Meri S (1994) Targeted neutralization of the complement membrane attack complex inhibitor CD59 on the surface of human melanoma cells. Eur J Immunol 24:611
12. Koretz K, Brüderlein C, Henne S, Möller P (1992) Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br J Cancer 66:810
13. Koretz K, Brüderlein C, Henne C, Möller P (1993) Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium. Br J Cancer 68:926
14. Kumar S, Vinci JM, Pytel BA, Baglioni C (1993) Expression of messenger RNAs for complement inhibitors in human tissues and tumors. Cancer Res 53:348
15. Lass JH, Walter EI, Burris TE, Grossniklaus HE, Roat MI, Skelnik DL, Needham L, Singer M, Medof ME (1990) Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest Ophthalmol Vis Sci 31:1136
16. Liszewski MK, Atkinson JP (1992) Membrane cofactor protein. Curr Top Microbiol Immunol 178:45
17. McNearney T, Ballard L, Seya T, Atkinson JP (1989) Membrane cofactor protein of complement is present on human fibroblast, epithelial, and endothelial cells. J Clin Invest 84:538
18. Medof ME, Walter EI, Rutgers JL, Knowles DM, Nussenzweig V (1987) Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med 165:848
19. Moran P, Beasley H, Gorrell A, Martin E, Gribling P, Fuchs H, Gillett N, Burton LE, Caras IW (1992) Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo. J Immunol 149:1736
20. Morgan PB (1989) Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 264:1
21. Moutabarrik A, Nakanishi I, Matsumoto M, Zaid D, Seya T (1993) Cytokine-mediated regulation of the secretion of third component of the complement (C3) and surface expression of complement regulatory proteins, CD46 (MCP), CD55 (DAF), and CD59 on human glomerular epithelial cells (GEC). Mol Immunol 30:36
22. Moutabarrik A, Nakanishi I, Namiki M, Hara T, Matsumoto M, Ishibashi M, Okuyama A, Zaid D, Seya T (1993) Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46 (MCP), CD55 (DAF), and CD59 on human vascular endothelial cells. Lymphokine Cytokine Res 12:167
23. Nicholson-Weller A (1992) Decay accelerating factor. Curr Top Microbiol Immunol 178:7
24. Niculescu F, Rus HG, Retegan M, Vlaicu R (1992) Persistent complement activation on tumour cells in breast cancer. Am J Pathol 140:1039
25. Panneerselvam M, Welt S, Old LJ, Vogel C-W (1986) A molecular mechanism of complement resistance of human melanoma cells. J Immunol 136:2534
26. Parezyk K, Pilarsky C, Rachel V, Koch-Brandt C (1994) Gp80 (clusterin; TRPM-2) mRNA level is enhanced in human renal clear cell carcinomas. J Cancer Res Clin Oncol 120:186
27. Parham P (1983) On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol 131:2895
28. Pinto M, Appay M-D, Simon-Assmann P, Chervalier G, Dracopoli N, Fogh J, Zweibaum A (1982) Enterocytic differentiation of cultured colon cancer cells by replacement of glucose by galactose in the medium. Biol Cell 44:193
29. + macrophages in antitumor cytotoxicily. Lab Invest 67:166
30. Reid KBM (1986) Activation and control of the complement system. Essays Biochem 22:27
31. Reiter Y, Ciobotariu A, Fishelson Z (1992) Sublytic complement attack protects tumour cells from lytic doses of antibody and complement. Eur J Immunol 22:1207
32. Schmitt C, Schwaeble W, Wittig B, Meyer zum Büschenfelde KH, Dippold W (1994) Expression and regulation of the membrane associated complement-regulators CD46, CD55 and CD59 in gastrointestinal cells. Gastroenterology 106:768
33. Seto N, Takemura S, Ueda M, Nakanishi S, Ichio N, Ashihara K, Nakahara R, Doi T, Kasamatsu Y, Okamoto M, Yanagida K, Fukuda W, Onodera H, Deguchi M, Sugino S, Kondo M (1993) Expression of membrane co-factor protein (MCP) in gastro-intestinal mucosa. Molecular Immunol 30:50
34. Seya T, Hara T, Matsumoto M, Akedo H (1990) Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J Immunol 145:238
35. Seya T, Hara T, Matsumoto M, Sugita Y, Akedo H (1990) Complement-mediated tumour cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J Exp Med 172:1673
36. Tandon N, Yan SL, Morgan BP, Weetman AP (1994) Expression and function of multiple regulators of complement activation in autoimmune thyroid disease. Immunology 81:643
37. Terachi T, Stanescu G, Pontes JE, Medof ME, Caulfield MJ (1991) Coexistence of autologous antibodies and decay-accelerating factor, in inhibitor of complement, on human renal tumour cells. Cancer Res 51:2521
38. Yamakawa M, Yamada K, Tsuge T, Ohrui H, Ogata T, Dobashi M, Imai Y (1994) Protection of thyroid cancer cells by complement-regulatory factors. Cancer 73:2808